Filter Results:
(1,203)
Show Results For
- All HBS Web
(1,203)
- People (5)
- News (334)
- Research (709)
- Events (1)
- Multimedia (17)
- Faculty Publications (457)
Show Results For
- All HBS Web
(1,203)
- People (5)
- News (334)
- Research (709)
- Events (1)
- Multimedia (17)
- Faculty Publications (457)
Strategies for Two-Sided Markets
Many blockbuster products and services that have redefined the global business landscape are built around platforms that tie together two distinct groups of users in a network. Examples include credit cards that link consumers and merchants; operating systems that... View Details
- 21 Oct 2013
- News
Negotiation Strategies for Doctors — and Hospitals
- 2020
- Working Paper
Spreading the Health: Americans' Estimated and Ideal Distributions of Death and Health(care)
By: Sorapop Kiatpongsan and Michael I. Norton
The 2010 Patient Protection and Affordable Care Act intensified debates over the role of government in the distribution of healthcare. A nationally-representative sample of Americans reported their estimated and ideal distributions of healthcare (unmet need for... View Details
Keywords: Healthcare; Mortality; Inequality; Justice; Equity; Health; Health Care and Treatment; Equality and Inequality; Fairness; Public Opinion; United States
Kiatpongsan, Sorapop, and Michael I. Norton. "Spreading the Health: Americans' Estimated and Ideal Distributions of Death and Health(care)." Harvard Business School Working Paper, No. 20-114, April 2020.
- 06 Sep 2019
- Blog Post
The Business of Medicine: MD/MBA Students Having an Impact
Zaki realized that poor infrastructure was the main barrier to accessing medical care. “If the roads weren’t paved or there wasn’t a functioning ambulance to get a patient to an appropriate health care... View Details
- 2020
- Working Paper
Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design
By: Scott Duke Kominers, Parag A. Pathak, Tayfun Sönmez and M. Utku Ünver
COVID-19 convalescent plasma (CCP) therapy is currently a leading treatment for COVID-19. At present, there is a shortage of CCP relative to demand. We develop and analyze a model of centralized CCP allocation that incorporates both donation and distribution. In order... View Details
Keywords: COVID-19; Convalescent Plasma; Vouchers; Health Pandemics; Health Care and Treatment; Resource Allocation; Market Design
Kominers, Scott Duke, Parag A. Pathak, Tayfun Sönmez, and M. Utku Ünver. "Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design." Harvard Business School Working Paper, No. 20-116, May 2020. (NBER Working Paper Series, No. 27143, May 2020.)
- September 2022
- Case
Proactive for Her
By: Rembrand Koning and Kairavi Dey
Proactive for Her began amid the COVID-19 pandemic, in August 2020 as a digital platform to provide accessible, evidence-based, primary, preventive non-judgmental healthcare services for Indian women, who were often dissuaded from seeking help as premarital sex and... View Details
Keywords: Women's Health; Healthcare; India; Start-up; Telehealth; Digital Platforms; Health Care and Treatment; Customer Focus and Relationships; Business Startups; Health Industry; Asia; South Asia; India
Koning, Rembrand, and Kairavi Dey. "Proactive for Her." Harvard Business School Case 723-351, September 2022.
- April 2012
- Article
Addressing the Leadership Gap in Medicine: Residents' Need for Systematic Leadership Development Training
By: Daniel Mark Blumenthal, Kenneth Richard Lee Bernard, Jordan David Bohnen and Richard Bohmer
All clinicians take on leadership responsibilities when delivering care. Evidence suggests that effective clinical leadership yields superior clinical outcomes. However, few residency programs systematically teach all residents how to lead, and many clinicians are... View Details
- 09 Apr 2013
- First Look
First Look: April 9
offered by Blue Cross Blue Shield of Massachusetts, providers received a fixed-dollar budget to cover all care provided to a specific patient population, as well as incentive payments for quality. The AQC... View Details
Keywords: Sean Silverthorne
- Research Summary
Overview of Research
My research examines approaches to improving the performance of our health care delivery system with a primary focus on health information technology. Reflecting the interdisciplinary nature of my program, my dissertation draws upon theories and insights from... View Details
- Article
Do We Spend Too Much on Health Care?
By: Katherine Baicker and Amitabh Chandra
Health system reforms—such as changes in insurance design, patient cost sharing, payment reform, or price regulation—should be judged by whether they move us toward higher-value use of resources, rather than by whether they reduce spending. View Details
Keywords: Health Care and Treatment; Cost; Governing Rules, Regulations, and Reforms; Value Creation
Baicker, Katherine, and Amitabh Chandra. "Do We Spend Too Much on Health Care?" New England Journal of Medicine 383, no. 7 (August 13, 2020): 605–608.
- May 2009 (Revised October 2009)
- Case
Newton-Wellesley Hospital
By: Richard M.J. Bohmer and Natalie Kindred
How will Newton-Wellesley Hospital (NWH) preserve its private practice tradition while remaining effective and competitive in a healthcare industry demanding increasing integration between physicians and hospitals? This is the decision facing Newton-Wellesley Hospital... View Details
Keywords: Business Model; Profit; Health Care and Treatment; Growth and Development Strategy; Organizational Change and Adaptation; Organizational Structure; Competitive Strategy; Integration; Health Industry; Massachusetts
Bohmer, Richard M.J., and Natalie Kindred. "Newton-Wellesley Hospital." Harvard Business School Case 609-088, May 2009. (Revised October 2009.)
- 25 Feb 2025
- Blog Post
Making a Broader Impact with Multiple Disciplines: Santosh Iyer (MBA 2020)
platform dedicated to revolutionizing health care innovation through experiential learning. Autonomous surgical robots, health care artificial intelligence, targeted therapeutics, and AR/VR surgery—what was... View Details
- February 2000 (Revised April 2001)
- Case
Boston Medical Group
By: Richard M.J. Bohmer and Bruce L. Hall
Describes the structure of a variable compensation plan for physicians implemented by a Massachusetts medical group practice. Examines issues such as balancing group and individual risk and selection of performance metrics (productivity and patient satisfaction). View Details
Keywords: Customer Satisfaction; Health Care and Treatment; Executive Compensation; Management Practices and Processes; Risk Management; Standards; Risk and Uncertainty; Health Industry
Bohmer, Richard M.J., and Bruce L. Hall. "Boston Medical Group." Harvard Business School Case 600-086, February 2000. (Revised April 2001.)
- 26 May 2015
- First Look
First Look: May 26
health care professionals, physicians are challenged to minimize the likelihood of errors that could harm patients while simultaneously making efforts to understand the causes of illnesses and develop better... View Details
Keywords: Sean Silverthorne
- 12 Aug 2019
- Working Paper Summaries
Case Histories of Significant Medical Advances
- September 2024
- Case
Myeloma Investment Fund
By: Kyle Myers and Scott Sawaya
This case explores a critical decision facing the Myeloma Investment Fund (MIF) as it evaluates two investment opportunities aimed at accelerating a cure for multiple myeloma.
The MIF, a venture philanthropy fund, must choose between two distinct paths. One... View Details
The MIF, a venture philanthropy fund, must choose between two distinct paths. One... View Details
Keywords: Venture Philanthropy; Biomedical Research; Investing For Impact; Innovation & Entrepreneurship; Venture Capital; Science-Based Business; Philanthropy and Charitable Giving; Decision Making; Health Care and Treatment; Biotechnology Industry; Pharmaceutical Industry
Myers, Kyle, and Scott Sawaya. "Myeloma Investment Fund." Harvard Business School Case 625-047, September 2024.
- Research Summary
Clinical Trials as a setting for Health Policy and Management Research
The clinical trial marketplace is in flux. A decade ago, pharmaceutical firms almost exclusively conducted the study of their novel drug compounds within major academic medical centers. But today, industry-sponsored clinical trials are increasingly using community... View Details
- Article
A Cost Comparison of Cataract Surgeries in Three Countries—United States, India, and Nepal
By: Jiayin Xue, John Hinkle, Mary-Grace Reeves, Luo Luo Zheng, Vengadesan Natarajan, Shyam Vyas, Radhika Upreti Oli, Matt Oliva, Robert S. Kaplan, Arnold Milstein, Geoff Tabin, Jeffrey L. Goldberg and Kevin Schulman
U.S.-based cataract surgeries are costly compared with those performed in high-quality Indian and Nepalese eye centers. The authors used time-driven activity-based costing to evaluate phacoemulsification surgery across four sites: a U.S.-based academic hospital... View Details
Keywords: Time-Driven Activity-Based Costing; Cost Accounting; Health Care and Treatment; Health Industry; India; Nepal; United States
Xue, Jiayin, John Hinkle, Mary-Grace Reeves, Luo Luo Zheng, Vengadesan Natarajan, Shyam Vyas, Radhika Upreti Oli, Matt Oliva, Robert S. Kaplan, Arnold Milstein, Geoff Tabin, Jeffrey L. Goldberg, and Kevin Schulman. "A Cost Comparison of Cataract Surgeries in Three Countries—United States, India, and Nepal." NEJM Catalyst Innovations in Care Delivery 2, no. 9 (September 2021).
- August 2001 (Revised March 2008)
- Case
Helios Health (A)
By: Regina E. Herzlinger and Alfred Martin
Helios PC system provides personalized drug information to the patients in the doctor's waiting room. It has met with considerable consumer acceptance and a very high return for the drug companies that sponsor it. What price should it charge them for the service? View Details
Keywords: Entrepreneurship; Price; Health Care and Treatment; Information Publishing; Innovation and Invention; Product Marketing; Demand and Consumers; Health Industry; Pharmaceutical Industry
Herzlinger, Regina E., and Alfred Martin. "Helios Health (A)." Harvard Business School Case 302-022, August 2001. (Revised March 2008.)
- January 2018
- Article
The Central and Unacknowledged Role of the U.S. Food and Drug Administration in the Design and Execution of Medical Device Pivotal Trials
By: Aaron V. Kaplan and Ariel D. Stern
The introduction of new medical devices has transformed cardiovascular care in recent decades. Devices, such as heart valves, pacemakers, stents, ventricular assist devices, and implantable defibrillators, have prolonged and improved the quality of life for millions of... View Details
Keywords: Health Testing and Trials; Business and Government Relations; Governing Rules, Regulations, and Reforms; Information Publishing; Medical Devices and Supplies Industry; United States
Kaplan, Aaron V., and Ariel D. Stern. "The Central and Unacknowledged Role of the U.S. Food and Drug Administration in the Design and Execution of Medical Device Pivotal Trials." JAMA Cardiology 3, no. 1 (January 2018): 5–6.